Charité – Universitätsmedizin Berlin is one of Europe’s largest and most prestigious university hospitals, combining excellent patient care with pioneering biomedical research. At the intersection of medicine, biology, and data science, Charité develops innovative approaches for the precision medicine of tomorrow.
This position is embedded in the newly established Einstein Center for Early Disease Interception (EC-EDI), a consortium of leading Berlin institutions including Charité, the Berlin Institute of Health (BIH), Max Delbrück Center, and TU Berlin. The center’s mission is to diagnose and intercept diseases at their earliest stages – when only a few cells are affected – using cutting-edge single-cell technologies, advanced AI, and patient-derived disease models. The successful candidate will work jointly with two research groups:
The Buchauer Lab (“Systems Biology of Infectious Diseases”) at Charité’s Department of Infectious Diseases develops computational methods to decode immune responses to infections and vaccines, combining single-cell omics data, mathematical modeling, and machine learning.
The Haas Lab (“Systems Hematology, Stem Cells & Precision Medicine”) at BIH/Charité/MDC-BIMSB develops and applies multimodal single-cell and spatially resolved technologies to study cancer etiology and immune-cell interactions. The lab has pioneered next-generation precision diagnostic tools based on single-cell multi-omics, recently developing up to 50-plex full-spectrum flow cytometry assays with near single-cell genomics resolution.
Develop translational algorithms for early disease interception in Berlin
As part of the Einstein Center for Early Disease Interception, we are recruiting a PhD student to develop computational methods enabling rapid, data-driven diagnosis of lung diseases.
Our goal is to build an “immune ecotype” framework that transforms single-cell RNA sequencing data from blood samples into interpretable feature vectors, enabling machine learning-based classification of lung diseases including viral and bacterial infections, autoimmune conditions, and lung cancer. We aim to translate these scRNA-seq-derived signatures to ultra-high-plex flow cytometry for clinical deployment.
Your Tasks:
Required:
Desirable:
Please send your motiviation letter, CV (including contacts of ideally two references) and master’s certificate and/or current transcript to lisa.buchauer@charite.de.
ID: 200422